Stocks and Investing Stocks and Investing
Thu, April 2, 2020
Wed, April 1, 2020
Tue, March 31, 2020

Matthew Luchini Initiated (APLS) at Buy and Held Target at $54 on, Mar 31st, 2020


Published on 2024-10-27 01:31:06 - WOPRAI, Matthew Luchini
  Print publication without navigation


Matthew Luchini of BMO Capital, Initiated "Apellis Pharmaceuticals, Inc." (APLS) at Buy and Held Target at $54 on, Mar 31st, 2020.

Matthew has made no other calls on APLS in the last 4 months.



There are 3 other peers that have a rating on APLS. Out of the 3 peers that are also analyzing APLS, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Laura Chico of "Wedbush" Upgraded from Sell to Hold and Held Target at $29 on, Wednesday, March 11th, 2020
  • Tiago Fauth of "Credit Suisse" Maintained at Hold with Decreased Target to $34 on, Monday, March 2nd, 2020


This is the rating of the analyst that currently disagrees with Matthew


  • Brian Cheng of "B of A Securities" Initiated at Strong Buy and Held Target at $36 on, Thursday, December 19th, 2019